GeneDx Holdings Corp. (WGS)

GeneDx Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	393.58	302.16	195.65	227.33	205.1	175.35
Other Revenue	8.61	3.29	6.91	7.36	7.1	3.97
Revenue	402.19	305.45	202.57	234.69	212.2	179.32
Revenue Growth (YoY)	50.50%	50.79%	-13.69%	10.60%	18.33%	-8.59%
Cost of Revenue	122.08	111	116.06	259.52	228.8	155.73
Gross Profit	280.11	194.45	86.51	-24.82	-16.6	23.6
Selling, General & Admin	206.12	166.93	191.49	338.24	324.39	173.32
Research & Development	58.92	45.57	55.09	86.2	105.16	72.7
Other Operating Expenses	3.41	3.41	5.27	6.31	-	-
Operating Expenses	268.45	215.91	251.85	430.76	429.55	246.02
Operating Income	11.66	-21.46	-165.34	-455.58	-446.15	-222.42
Interest Expense	-2.72	-3.03	-	-0.67	-2.84	-2.47
Interest & Investment Income	-	-	1.11	-	0.08	0.51
Other Non Operating Income (Expenses)	11.45	-13.6	1.17	60.09	198.22	0.02
EBT Excluding Unusual Items	20.39	-38.09	-163.06	-396.16	-250.69	-224.37
Merger & Restructuring Charges	-1.7	-1.75	-6.53	-1.93	-	-
Gain (Loss) on Sale of Assets	-	-	1.68	-	-	-
Asset Writedown	-	-	-10.4	-210.15	-	-
Legal Settlements	-12.79	-12.79	-	-	-	-
Other Unusual Items	-3.4	-	1.62	10.2	5.3	-16.97
Pretax Income	2.51	-52.63	-176.69	-598.03	-245.39	-241.34
Income Tax Expense	0.42	-0.34	-0.93	-49.05	-	-
Net Income	2.08	-52.29	-175.77	-548.98	-245.39	-241.34
Net Income to Common	2.08	-52.29	-175.77	-548.98	-245.39	-241.34
Shares Outstanding (Basic)	28	27	24	10	3	-
Shares Outstanding (Diluted)	28	27	24	10	3	-
Shares Change (YoY)	7.19%	10.61%	137.49%	212.57%	-	-
EPS (Basic)	0.07	-1.94	-7.23	-53.63	-74.93	-
EPS (Diluted)	0.07	-1.94	-7.23	-53.63	-74.93	-
Free Cash Flow	15.47	-33.99	-185.4	-326.31	-199.83	-117.22
Free Cash Flow Per Share	0.55	-1.26	-7.63	-31.88	-61.02	-
Gross Margin	69.65%	63.66%	42.71%	-10.58%	-7.82%	13.16%
Operating Margin	2.90%	-7.03%	-81.62%	-194.12%	-210.25%	-124.04%
Profit Margin	0.52%	-17.12%	-86.77%	-233.91%	-115.64%	-134.59%
Free Cash Flow Margin	3.84%	-11.13%	-91.52%	-139.04%	-94.17%	-65.37%
EBITDA	34.66	-0.41	-138.21	-439.67	-429.94	-213.69
EBITDA Margin	8.62%	-0.13%	-68.23%	-187.34%	-202.62%	-119.17%
D&A For EBITDA	23	21.05	27.13	15.91	16.21	8.73
EBIT	11.66	-21.46	-165.34	-455.58	-446.15	-222.42
EBIT Margin	2.90%	-7.03%	-81.62%	-194.12%	-210.25%	-124.04%
Revenue as Reported	402.19	305.45	202.57	234.69	212.2	179.32

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q